Oil Is the New Gold
Health Care: Drugs
Exact Sciences Corporation (EXAS: NASDAQ)
$12.90 0.07 | 0.55%
06/19/13 - 04:00 PM ET
1.32M / 1.64M
Vol / Avg. Vol:12.87 / 12.83
Open / Prev. Close:12.60 - 13.16
Today's Range:6.93 - 14.42
52 Wk Range:18.89%
Performance YTD:TheStreet Rating:
Portfolios with EXAS
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- Contributor22 Biopharma Stocks With Br...
- Contributor8 Health Care Stocks With R...
- Usergdean1
- Userradforj John's SEP & Ta...
- UserBlind Rookie
- Userbbrads Portfolio 1
- Userremodelit Portfolio 1
- UserGoBears Under $5 Stock Picks
- UserMornan
Latest EXAS Headlines from TheStreet
- Biotech Stock Mailbag: Exact Sciences, Questcor, Biotech M&A, Celsion 06.14.13 | 07:06 am
- EXACT Sciences (EXAS) Shares Cross Above 200 DMA 05.14.13 | 04:05 pm
- EXACT Sciences Becomes Oversold (EXAS) 04.18.13 | 12:04 pm
- Exact Sciences Colon Cancer Screen Results Disappoint Wall Street 04.18.13 | 08:04 am
- Biotech Stock Mailbag: Exact Sciences, Galena, Titan, Arena, Breakthrough Therapy 04.12.13 | 06:04 am
- Cramer's Top Stock Picks: ARCP OPK EXAS 04.06.13 | 06:04 am
- Cramer's 'Mad Money' Recap: Next Week's Game Plan 04.05.13 | 07:04 pm
- 6 Stocks Under $10 Spiking Higher 04.04.13 | 03:04 pm
- J.P. Morgan Healthcare Confab Live Blog Day Three 01.09.13 | 10:01 am
- Cramer's Top Stock Picks: NPSP BAC EXAS 01.08.13 | 06:01 am
Press Releases for EXAS
- Exact Sciences To Participate In 25th Annual Roth Conference - Business Wire 03.11.13 | 04:03 pm
- Exact Sciences Reports Fourth-Quarter 2012 Financial Results - Business Wire 02.20.13 | 07:02 am
- Exact Sciences Submits Second Module Of Premarket Approval Application To FDA - Business Wire 02.18.13 | 07:02 am
- Exact Sciences To Host Fourth-Quarter, Full-Year 2012 Results Webcast And Call - Business Wire 02.12.13 | 04:02 pm
- Exact Sciences To Participate In February Investor Conferences - Business Wire 02.12.13 | 11:02 am
- Exact Sciences To Participate In J.P. Morgan Healthcare Conference - Business Wire 01.03.13 | 09:01 am
- Exact Sciences Submits First Module Of Premarket Approval Application To FDA - Business Wire 12.10.12 | 04:12 pm
- Exact Sciences To Participate In Canaccord Genuity Medical Technology & Diagnostics Forum - Business Wire 11.29.12 | 12:11 pm
- Senior Research Associate II Tanya Quint At Work In The Exact Sciences' Lab In Madison, Wis. (Photo: Business Wire) - Business Wire 11.15.12 | 07:11 am
- Exact Sciences To Participate In November Investor Conferences - Business Wire 11.07.12 | 10:11 am
Partner Headlines for EXAS
- Testing, Testing: Analyst Kevin DeGeeter On 5 Good Bets In Cancer Diagnostics - Seeking Alpha 11.30.12 | 09:11 am
- Unum INITIATED at Buy and 3 Shares With Analyst-Initiated Coverage - Wall St. Cheat Sheet 07.18.12 | 03:07 am
- UPDATE: Auriga Raises PT to $13 on EXACT Sciences - Benzinga 02.24.12 | 04:02 pm
- Exact Sciences Promotes Arora to Chief Operating Officer - Benzinga 02.16.12 | 04:02 pm
- 10 Undervalued Biotech Stocks With Insider Buying - Seeking Alpha 06.23.11 | 06:06 am
- Momentum Ideas: Friday's High Volume Gainers Chased by Big Money Managers - Seeking Alpha 04.17.11 | 07:04 am
- Cramer's Mad Money - 6 Earnings and IPOs to Watch for the Coming Week (4/8/11) - Seeking Alpha 04.10.11 | 04:04 am
- Life Science Portfolios: Reflecting on a Year of Out-Performance - Seeking Alpha 12.29.10 | 05:12 am
- UPDATE1-New colon cancer test works without colonoscopy - Reuters 10.28.10 | 05:10 pm
- Detecting More Upside Potential for EXACT Sciences - Seeking Alpha 10.22.10 | 09:10 pm
